![Jon S. Kuwahara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jon S. Kuwahara
Corporate Officer/Principal chez
CRINETICS PHARMACEUTICALS, INC.
Profil
Jon S.
Kuwahara is Vice President-Finance at Crinetics Pharmaceuticals, Inc. since 2021.
Former positions include Director at EMI Holding, Inc.; Director at Emmaus Life Sciences, Inc. from 2016 to 2018 and from 2024 to 2026; Controller at Avanir Pharmaceuticals, Inc. from 2014 to 2016; Assistant Controller at Questcor Pharmaceuticals, Inc. from 2010 to 2014; CAO & SVP-Finance & Administration at Eledon Pharmaceuticals, Inc. in 2021; Vice President-Finance at Espero Pharmaceuticals, Inc. from 2016 to 2017.
Education includes undergraduate studies at the University of Hawai'i at Hilo.
Postes actifs de Jon S. Kuwahara
| Sociétés | Poste | Début |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2021 |
Anciens postes connus de Jon S. Kuwahara
| Sociétés | Poste | Fin |
|---|---|---|
| EMMAUS LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 15/04/2026 |
| ELEDON PHARMACEUTICALS, INC. | Directeur Général | 09/09/2020 |
| EMMAUS LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 01/09/2018 |
Espero Pharmaceuticals, Inc.
 Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Manufactures and supplies drugs related to cardiovascular | Corporate Officer/Principal | 01/06/2017 |
| AVANIR PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01/06/2016 |
Formation de Jon S. Kuwahara
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets and sells prescription drugs | Health Technology |
EMI Holding, Inc.
 EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
University of Hawai'i at Hilo
 University of Hawai'i at Hilo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Manufactures and supplies drugs related to cardiovascular | Distribution Services |
Eledon Pharmaceuticals, Inc.
 Eledon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Emmaus Life Sciences, Inc.
 Emmaus Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments and therapies for rare diseases | Health Technology |
